Oncolytics Biotech Inc. Collaborators To Present Updated Phase I/II Trial Results In Advanced Solid Cancers With A Focus On The Head And Neck

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

Oncolytics Biotech Inc. today announced that a poster presentation covering updated results of a Phase I/II U.K. trial (REO 011) of REOLYSIN (R) combined with paclitaxel/carboplatin for patients with advanced cancers will be presented on November 17, 2009 at the 2009 AACR- NCI-EORTC Molecular Targets and Cancer Therapeutics conference being held in Boston, Massachusetts.

 

0 Comments

You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.